Labeling of cell therapies: How can we get it right? - Wikidata - awgldk - TriplyDB

Labeling of cell therapies: How can we get it right?

Labeling of cell therapies: How can we get it right?

http://www.wikidata.org/entity/Q50538507

about

Fluorine-19 nuclear magnetic resonance of chimeric antigen receptor T cell biodistribution in murine cancer model.Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer

P2860

Q47148959-62500B08-7437-4862-8CD0-C9A3E0DBBD3C Q57280956-5ACE8471-3948-4DD0-97E2-3AE8BB057037

P2860

Labeling of cell therapies: How can we get it right?

http://www.wikidata.org/entity/Q50538507

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Labeling of cell therapies: How can we get it right?

@en

Labeling of cell therapies: How can we get it right?

@nl

type

label

Labeling of cell therapies: How can we get it right?

@en

Labeling of cell therapies: How can we get it right?

@nl

prefLabel

Labeling of cell therapies: How can we get it right?

@en

Labeling of cell therapies: How can we get it right?

@nl

P1433

Q50538507-02795C68-32A5-4084-8B6C-4EA771E26BBA

P1476

Q50538507-8364670A-7324-465C-A6FE-D96808193E1F

P2093

Q50538507-24B8ABC4-58D6-4B4C-96F6-3EB47D1D4533

Q50538507-A72FF807-CE6A-4071-A2C6-48A6CEB30B0F

P2860

Q50538507-113B66FA-867E-4EA3-8920-8C9642C9C7C1

Q50538507-11E1F4A9-AAB0-41A5-AC7C-C15EB7CFEA3D

Q50538507-122257A1-02C5-4883-B6F5-CC410BF30915

Q50538507-1B2A65FC-C4B1-42D4-98A3-FBC160E3D8C6

Q50538507-3476BC2B-311D-4BD4-97CD-64BFE2A21CEF

Q50538507-4E115643-039B-4697-AF03-835007B52CC8

Q50538507-5A8BF350-41B2-4AC7-8C61-CF84197641B7

Q50538507-5E97CA89-1624-4FB2-A357-946AC616A928

Q50538507-65E1990C-6302-4029-94B3-C0DD3CBB4128

Q50538507-67410F6C-FA9D-4E5E-982D-8DB4A7E8E265

P304

Q50538507-890E8B1E-FF42-4E89-8C6A-8A31BC6D96DC

P31

Q50538507-DB211392-C529-49DE-91FC-3FA8867018B5

P356

Q50538507-477BC566-FE71-42C6-997D-F9D7FB8DD199

P433

Q50538507-A39A61AB-E04E-430E-999D-6A4FD98C55D6

P478

Q50538507-7A748981-3023-4203-A304-21532AE79F46

P50

Q50538507-D8F94B17-7E50-4E58-AD6A-29ABAE1C4581

P577

Q50538507-29005FFF-1FCD-4F69-88FE-558D713A2E70

P698

Q50538507-264A44FD-9D32-4C2B-9CF9-8C52AC3BE699

P932

Q50538507-1D718CEB-F267-4F12-8540-83F383DDEE8E

P356

2162402X.2017.1345403

P1433

P1476

Labeling of cell therapies: How can we get it right?

@en

P2093

Giovanna Lombardi

http://www.w3.org/2001/XMLSchema#string

Thoralf Niendorf

http://www.w3.org/2001/XMLSchema#string

P2860

Using magnetic resonance imaging to evaluate dendritic cell-based vaccination

Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells

Nanoparticle Uptake: The Phagocyte Problem

Combining perfluorocarbon and superparamagnetic iron-oxide cell labeling for improved and expanded applications of cellular MRI.

β-Gal gene expression MRI reporter in melanoma tumor cells. Design, synthesis, and in vitro and in vivo testing of a Gd(III) containing probe forming a high relaxivity, melanin-like structure upon β-Gal enzymatic activation.

Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI.

Cell Labeling for 19F MRI: New and Improved Approach to Perfluorocarbon Nanoemulsion Design.

In-Vivo Detection and Tracking of T Cells in Various Organs in a Melanoma Tumor Model by 19F-Fluorine MRS/MRI.

(19)F-MRI for monitoring human NK cells in vivo

Reporter gene imaging.

P304

e1345403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2017.1345403

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29123957

http://www.w3.org/2001/XMLSchema#string

P932

5665073

http://www.w3.org/2001/XMLSchema#string